Evidence map›Paper›PMID 27647924›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2016

ACOX2 deficiency: A disorder of bile acid synthesis with transaminase elevation, liver fibrosis, ataxia, and cognitive impairment.

Sílvia Vilarinho, Sinan Sari, Francesca Mazzacuva, Kaya Bilgüvar, Güldal Esendagli-Yilmaz, Dhanpat Jain, Gülen Akyol, Buket Dalgiç, Murat Günel, Peter T Clayton and 1 more

Open access · bronzeAbstract readCase Reports
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 54 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
54citing papers in PubMed, 1 pooled it
6.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

54 citing papers in PubMed, 1 synthesis or guideline pooled it, 90 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Peroxisome Dysfunction and Steatotic Liver Disease.International journal of molecular sciences · 2025
    Review
  8. Article
  9. Impact ofTranslational gastroenterology and hepatology · 2025
    Article
  10. Liver as a nexus of daily metabolic cross talk.International review of cell and molecular biology · 2025
    Review
  11. Disorders of fatty acid homeostasis.Journal of inherited metabolic disease · 2025
    Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Protein crotonylation: Basic research and clinical diseases.Biochemistry and biophysics reports · 2024
    Review
  17. Genetics of liver disease in adults.Hepatology communications · 2024
    Review
  18. The Physiological and Pathological Role of Acyl-CoA Oxidation.International journal of molecular sciences · 2023
    Review
  19. Review
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 3 countries.

Sílvia VilarinhoSection of Digestive Diseases, Department of Internal Medicine, Yale University School of Medicine, New Haven, CT 06517; Department of Genetics, Yale University School of Medicine, New Haven, CT 06517; silvia.vilarinho@yale.edu rickl@rockefeller.edu.
Sinan SariDivision of Gastroenterology, Department of Pediatrics, Faculty of Medicine, Gazi University, Ankara, TB 06500, Turkey.
Francesca MazzacuvaCenter for Translational Omics, Institute of Child Health, University College London, London WC1N 1EH, United Kingdom.
Kaya BilgüvarDepartment of Genetics, Yale University School of Medicine, New Haven, CT 06517; Yale Center for Mendelian Genomics, Yale University School of Medicine, New Haven, CT 06517.
Güldal Esendagli-YilmazDepartment of Pathology, Faculty of Medicine, Gazi University, Ankara, TB 06500, Turkey.
Dhanpat JainSection of Digestive Diseases, Department of Internal Medicine, Yale University School of Medicine, New Haven, CT 06517; Department of Pathology, Yale University School of Medicine, New Haven, CT 06517.
Gülen AkyolDepartment of Pathology, Faculty of Medicine, Gazi University, Ankara, TB 06500, Turkey.
Buket DalgiçDivision of Gastroenterology, Department of Pediatrics, Faculty of Medicine, Gazi University, Ankara, TB 06500, Turkey.
Murat GünelDepartment of Genetics, Yale University School of Medicine, New Haven, CT 06517; Yale Center for Mendelian Genomics, Yale University School of Medicine, New Haven, CT 06517; Yale Program in Brain Tumor Research, Department of Neurosurgery, Yale University School of Medicine, New Haven, CT 06517.
Peter T ClaytonCenter for Translational Omics, Institute of Child Health, University College London, London WC1N 1EH, United Kingdom.
Richard P LiftonDepartment of Genetics, Yale University School of Medicine, New Haven, CT 06517; Yale Center for Mendelian Genomics, Yale University School of Medicine, New Haven, CT 06517; Department of Internal Medicine, Yale University School of Medicine, New Haven, CT 06517; Howard Hughes Medical Institute, Yale University School of Medicine, New Haven, CT 06517; Laboratory of Human Genetics and Genomics, The Rockefeller University, New York, NY 10065 silvia.vilarinho@yale.edu rickl@rockefeller.edu.
Gazi University · TRYale University · USUniversity College London · GBRockefeller University · US

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
Yale Liver CenterP30DK034989 · NIDDK · YALE UNIVERSITY · PI YASUKO IWAKIRI · 1986 to 2026
$31.1M
Yale Center for Mendelian DisordersU54HG006504 · NHGRI · YALE UNIVERSITY · PI GERSTEIN, MARK BENDER, GUNEL, MURAT · 2012 to 2015
$11.0M
NCATS NIH HHS UL1 TR001863NHGRI NIH HHS U54 HG006504NIDDK NIH HHS P30 DK034989
6 · The paper itself

Abstract

Acyl CoA Oxidase 2 (ACOX2) encodes branched-chain acyl-CoA oxidase, a peroxisomal enzyme believed to be involved in the metabolism of branched-chain fatty acids and bile acid intermediates. Deficiency of this enzyme has not been described previously. We report an 8-y-old male with intermittently elevated transaminase levels, liver fibrosis, mild ataxia, and cognitive impairment. Exome sequencing revealed a previously unidentified homozygous premature termination mutation (p.Y69*) in ACOX2 Immunohistochemistry confirmed the absence of ACOX2 expression in the patient's liver, and biochemical analysis showed marked elevation of intermediate bile acids upstream of ACOX2. These findings define a potentially treatable inborn error of bile acid biosynthesis caused by ACOX2 deficiency.

Indexed as

AtaxiaBile Acids and SaltsChildCognitive DysfunctionHomozygoteHumansInfantInfant, NewbornLiverLiver CirrhosisLoss of Function MutationMaleMutationOxidation-ReductionOxidoreductasesTransaminasesACOX2 protein, humanBile Acids and SaltsOxidoreductasesTransaminasesbile acid metabolismbranched-chain acyl-CoA oxidaseidiopathic liver diseaseperoxisomal disorderwhole-exome sequencing

Identifiers

PMID27647924
PMCPMC5056113
OpenAlexW2522639737

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.